PriceTargets.com logo

Ontrak - OTRK Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $45.00
  • Forecasted Upside: 2,471.43%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$1.75 As of 10/30/2024 03:55 PM ET
▼ -0.09 (-4.89%)

This chart shows the closing price for OTRK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ontrak Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OTRK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OTRK

Analyst Price Target is $45.00
▲ +2,471.43% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Ontrak in the last 3 months. The average price target is $45.00, with a high forecast of $45.00 and a low forecast of $45.00. The average price target represents a 2,471.43% upside from the last price of $1.75.

This chart shows the closing price for OTRK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in Ontrak. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/9/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/7/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/5/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/3/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/3/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/1/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/30/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/30/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/9/2024Roth MkmLower TargetBuy ➝ Buy$60.00 ➝ $45.00
12/5/2023Roth CapitalReiterated RatingBuy
12/5/2023Roth MkmInitiated CoverageBuy$60.00
8/11/2022BenchmarkLower Target$360.00 ➝ $270.00
5/17/2022CowenLower Target$810.00 ➝ $117.00
5/12/2022BenchmarkLower Target$450.00 ➝ $360.00
3/9/2022BenchmarkLower Target$1,440.00 ➝ $450.00
8/20/2021BenchmarkLower TargetBuy$3,150.00 ➝ $1,440.00
8/20/2021B. RileyDowngradeBuy ➝ Neutral$5,220.00 ➝ $1,350.00
8/19/2021CowenDowngradeMarket Perform ➝ Underperform$3,150.00 ➝ $810.00
8/6/2021BenchmarkLower TargetBuy$3,600.00 ➝ $3,150.00
5/10/2021B. RileyLower TargetBuy$6,570.00 ➝ $5,220.00
3/17/2021BenchmarkBoost TargetBuy$3,600.00 ➝ $4,500.00
3/8/2021Royal Bank of CanadaReiterated RatingOutperform ➝ Sector Perform$7,380.00 ➝ $2,880.00
3/8/2021CowenReiterated RatingOutperform ➝ Market Perform$6,750.00 ➝ $3,150.00
3/2/2021B. RileyLower TargetBuy$9,900.00 ➝ $6,570.00
3/2/2021CowenDowngradeOutperform ➝ Market Perform$6,750.00 ➝ $3,150.00
3/1/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$7,380.00 ➝ $2,880.00
1/4/2021B. RileyBoost TargetOutperform ➝ Buy$9,000.00 ➝ $9,900.00
11/18/2020B. RileyInitiated CoverageBuy$9,000.00
9/25/2020BenchmarkInitiated CoverageBuy$9,000.00
9/8/2020Royal Bank of CanadaBoost Target$4,500.00 ➝ $7,380.00
8/6/2020Royal Bank of CanadaBoost Target$3,150.00 ➝ $4,500.00
7/16/2020CowenInitiated CoverageOutperform$3,240.00
4/20/2020Royal Bank of CanadaInitiated CoverageOutperform$3,150.00
(Data available from 10/30/2019 forward)

News Sentiment Rating

1.49 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/3/2024
  • 0 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/3/2024
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/2/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/2/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2024
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/31/2024
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/30/2024
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2024

Current Sentiment

  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Ontrak logo
Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.
Read More

Today's Range

Now: $1.75
Low: $1.75
High: $1.89

50 Day Range

MA: $2.72
Low: $1.82
High: $3.63

52 Week Range

Now: $1.75
Low: $1.75
High: $21.29

Volume

40,211 shs

Average Volume

663,199 shs

Market Capitalization

$7.38 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.56

Frequently Asked Questions

What sell-side analysts currently cover shares of Ontrak?

The following sell-side analysts have issued stock ratings on Ontrak in the last twelve months: Roth Capital, and Roth Mkm.
View the latest analyst ratings for OTRK.

What is the current price target for Ontrak?

1 Wall Street analysts have set twelve-month price targets for Ontrak in the last year. Their average twelve-month price target is $45.00, suggesting a possible upside of 2,471.4%. Roth Mkm has the highest price target set, predicting OTRK will reach $45.00 in the next twelve months. Roth Mkm has the lowest price target set, forecasting a price of $45.00 for Ontrak in the next year.
View the latest price targets for OTRK.

What is the current consensus analyst rating for Ontrak?

Ontrak currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OTRK will outperform the market and that investors should add to their positions of Ontrak.
View the latest ratings for OTRK.

What other companies compete with Ontrak?

Other companies that are similar to Ontrak include Concord Medical Services, Burning Rock Biotech, ATI Physical Therapy, Oncology Institute and Renalytix. Learn More about companies similar to Ontrak.

How do I contact Ontrak's investor relations team?

Ontrak's physical mailing address is 2120 COLORADO AVE SUITE 230, SANTA MONICA CA, 90404. The company's listed phone number is (310) 444-4300 and its investor relations email address is [email protected]. The official website for Ontrak is ontrakhealth.com. Learn More about contacing Ontrak investor relations.